US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
180 Life Sciences Corporation (ATNF)
180 Life Sciences Corporation (ATNF) ニュース

ATNF

180 Life Sciences (ATNF)

180 Life Sciences Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ATNF

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/14	21 : 30	GlobeNewswire Inc.	180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:ATNF	180 Life Sciences Corporation
2024/03/11	20 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/03/09	06 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/29	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/28	20 : 42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/28	20 : 39	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/28	20 : 37	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/28	20 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/26	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/26	21 : 00	GlobeNewswire Inc.	180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/20	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/17	07 : 10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/17	07 : 08	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/17	07 : 05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/17	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/13	06 : 15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ATNF	180 Life Sciences Corporation
2024/02/01	07 : 29	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:ATNF	180 Life Sciences Corporation
2024/01/29	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/01/17	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2024/01/16	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/29	08 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/28	06 : 15	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/27	06 : 15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/22	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/20	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/19	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/15	22 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/15	06 : 30	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/04	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATNF	180 Life Sciences Corporation
2023/12/04	23 : 00	GlobeNewswire Inc.	180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives	NASDAQ:ATNF	180 Life Sciences Corporation

Showing the most relevant articles for your search:NASDAQ:ATNF

1 2 3 4 5 6 7 8 9 10 次へ >>

Marimaca Copper (QX)

Jungheinrich (PK)

Avino Silver and Gold Mi...

Goldcliff Resource (PK)

iREIT Marketvector Quali...

Amundi MSCI AC Asia Ex J...

Pepcap Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約